(Q33494125)

English

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

author name string

Scheithauer W

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Kornek G

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Haider K

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Kwasny W

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Schenk T

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pirker R

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Depisch D

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

49-53

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Response and survival in advanced breast cancer after two non-cross-resistant combinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitomycin C and vinblastine in the treatment of advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Navelbine: a new step in cancer therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitomycin C and vinblastine chemotherapy for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of amonafide in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapy in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitomycin-C and vinblastine in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapy for metastatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8400323

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00682699

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

release_sz3um2km45fx3i276twilabm4a

1 reference

https://api.fatcat.wiki/v0/release/sz3um2km45fx3i276twilabm4a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33494125&oldid=2195414014"